glp-1 news today cardiovascular outcomes 2025 november Agonists Market Report 2025-2033, By Product, Molecule, and Geo The GLP-1 Revolution Continues

I felt my metabolism picking up, and my energy levels soaring

Modern healthcare providers and patients are increasingly focused on incorporating GLP-1 therapies to enhance treatment outcomes while satisfying demands for comprehensive diabetes care, including weight management and cardiovascular protection

Granted, I am biased, but I am proud of what the team has delivered

Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss

The trial was small and short, and the participants were predominantly already taking metformin (some with a sulfonylurea) alongside diet and exercise, which makes it hard to isolate the probiotic's specific contribution